| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1309/AJCPJI7DEOLKCS6F |
| P698 | PubMed publication ID | 19605818 |
| P2093 | author name string | Jeffrey S Ross | |
| Elzbieta A Slodkowska | |||
| P2860 | cites work | Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. | Q55043149 |
| Isolation of rare circulating tumour cells in cancer patients by microchip technology | Q24597164 | ||
| Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases | Q28289395 | ||
| The distribution of secondary growths in cancer of the breast. 1889 | Q29614314 | ||
| Circulating tumor cells, disease progression, and survival in metastatic breast cancer | Q29619276 | ||
| Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection | Q33245050 | ||
| American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer | Q33303529 | ||
| A progression puzzle | Q33337505 | ||
| Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease | Q33922686 | ||
| Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer | Q34398320 | ||
| Commercialized multigene predictors of clinical outcome for breast cancer. | Q34783293 | ||
| Dissecting the metastatic cascade | Q35788115 | ||
| Tumor cell detection in peripheral blood and bone marrow | Q36343282 | ||
| Circulating tumor cells, disease progression, and survival in metastatic breast cancer | Q36517263 | ||
| A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation | Q36549817 | ||
| HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management? | Q36609893 | ||
| Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance | Q37019257 | ||
| Circulating tumor cells: detection, molecular profiling and future prospects | Q37027492 | ||
| The prognostic implications of circulating tumor cells in patients with breast cancer | Q37079905 | ||
| Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. | Q37090760 | ||
| Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization | Q37188292 | ||
| Circulating tumor cells and bone marrow micrometastasis | Q37242269 | ||
| Review: Biological relevance of disseminated tumor cells in cancer patients | Q37246973 | ||
| Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay | Q39370156 | ||
| Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells | Q40121443 | ||
| HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients | Q40341072 | ||
| Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction | Q41656564 | ||
| Correlation among [18F]fluorodeoxyglucose positron emission tomography/computed tomography, cancer antigen 27.29, and circulating tumor cell testing in metastatic breast cancer. | Q43706539 | ||
| A pooled analysis of bone marrow micrometastasis in breast cancer | Q44594123 | ||
| HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer | Q46713075 | ||
| Case study of the morphologic variation of circulating tumor cells. | Q51091573 | ||
| Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer. | Q53012804 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 237-245 | |
| P577 | publication date | 2009-08-01 | |
| P1433 | published in | American Journal of Clinical Pathology | Q15750224 |
| P1476 | title | Circulating and disseminated tumor cells in the management of breast cancer | |
| P478 | volume | 132 |
| Q34289862 | A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire. |
| Q44171648 | A wake-up call for hibernating tumour cells |
| Q38114779 | Advances of lab-on-a-chip in isolation, detection and post-processing of circulating tumour cells |
| Q34156275 | Analysis of circulating tumor cells in breast cancer |
| Q39123704 | Application of an improved magnetic immunosorbent in an Ephesia chip designed for circulating tumor cell capture |
| Q37886995 | Biomarker-based selection of therapy for colorectal cancer |
| Q48148624 | Breast metastasis from vaginal cancer |
| Q34238076 | Breast tumor cell detection at single cell resolution using an electrochemical impedance technique. |
| Q24615405 | CD133: to be or not to be, is this the real question? |
| Q50027179 | Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases |
| Q97644957 | Circulating Tumor Cells Detection in Patients with Early Breast Cancer Using MACS Immunomagnetic Flow Cytometry |
| Q26752116 | Circulating tumor cells in germ cell tumors: are those biomarkers of real prognostic value? A review |
| Q24634952 | Circulating tumor cells: finding the needle in the haystack |
| Q37274573 | Cytokeratin-based CTC counting unrelated to clinical follow up |
| Q43685849 | Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy. |
| Q57722872 | Detection, manipulation and post processing of circulating tumor cells using optical techniques |
| Q35543094 | Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology |
| Q36262506 | Enrichment and Molecular Analysis of Breast Cancer Disseminated Tumor Cells from Bone Marrow Using Microfiltration |
| Q42008988 | Epithelial mesenchymal transition: a new insight into the detection of circulating tumor cells |
| Q37001808 | Incidence of prostate, breast, lung and colorectal cancer following new consultation for musculoskeletal pain: a cohort study among UK primary care patients. |
| Q34590296 | Insulin-like growth factor receptor I (IGF-IR) and vascular endothelial growth factor receptor 2 (VEGFR-2) are expressed on the circulating epithelial tumor cells of breast cancer patients |
| Q37894736 | Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications |
| Q55187959 | Liquid biopsy in pancreatic cancer: the beginning of a new era. |
| Q64244685 | Low Levels of Sox2 are required for Melanoma Tumor-Repopulating Cell Dormancy |
| Q37763495 | Lung cancer stem cells: tools and targets to fight lung cancer. |
| Q37812167 | Methods of detection of circulating melanoma cells: A comparative overview |
| Q50055191 | Microarray-based SNP genotyping to identify genetic risk factors of triple-negative breast cancer (TNBC) in South Indian population |
| Q39172101 | Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146. |
| Q97636319 | Minimal residual disease-a novel concept in uveal melanoma |
| Q64106622 | Molecular Subtype Conversion between Primary and Metastatic Breast Cancer Corresponding to the Dynamics of Apoptotic and Intact Circulating Tumor Cells |
| Q35591546 | Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy |
| Q37967661 | Nanobiotechnology for the capture and manipulation of circulating tumor cells |
| Q33915061 | Neither epithelial nor mesenchymal circulating tumor cells isolated from breast cancer patients are tumorigenic in NOD-scid Il2rgnull mice |
| Q33807851 | Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma |
| Q38293612 | Pivotal role of pervasive neoplastic and stromal cells reprogramming in circulating tumor cells dissemination and metastatic colonization. |
| Q47100389 | Precisely Enumerating Circulating Tumor Cells Utilizing a Multi-Functional Microfluidic Chip and Unique Image Interpretation Algorithm |
| Q28743108 | Predictive and prognostic molecular markers for cancer medicine |
| Q85995802 | Prognostic value of EpCAM/MUC1 mRNA-positive cells in non-small cell lung cancer patients |
| Q36564851 | Rapid isolation of cancer cells using microfluidic deterministic lateral displacement structure |
| Q38159963 | Rapid translation of circulating tumor cell biomarkers into clinical practice: technology development, clinical needs and regulatory requirements |
| Q37241255 | Role of RANKL/RANK in primary and secondary breast cancer |
| Q35807183 | Sampling circulating tumor cells for clinical benefits: how frequent? |
| Q87036470 | Survivin mRNA-circulating tumor cells predict treatment efficacy of chemotherapy and survival for advanced non-small cell lung cancer patients |
| Q52608415 | The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation. |
| Q39132753 | The liquid biopsy in lung cancer |
| Q36849660 | The potential for liquid biopsies in the precision medical treatment of breast cancer |
| Q82222981 | The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy |
Search more.